SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-175515
Filing Date
2022-06-16
Accepted
2022-06-16 16:14:56
Documents
12
Period of Report
2022-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d350279d8k.htm   iXBRL 8-K 33052
  Complete submission text file 0001193125-22-175515.txt   151456

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alxo-20220614.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20220614_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20220614_pre.xml EX-101.PRE 10821
6 EXTRACTED XBRL INSTANCE DOCUMENT d350279d8k_htm.xml XML 3290
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 221020740
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences